The total return over the past 12 months is -85.62% vs. +16.94% for the S&P 500. So far it's up -70.78% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (85.62%) | (60.39%) | (61.41%) | N/A | N/A | N/A |
| Total Return CAGR | (85.62%) | (60.39%) | (61.41%) | N/A | N/A | N/A |
| Revenue CAGR | (25.00%) | (9.14%) | +0.29% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Silo Pharma, Inc. (SILO)
| Year | Start price | End price | SILO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.10 | $1.49 | (70.78%) | +14.51% | (85.29%) |
| 2025 | $13.35 | $5.10 | (61.80%) | +17.72% | (79.52%) |
| 2024 | $21.60 | $13.35 | (38.19%) | +24.89% | (63.08%) |
| 2023 | $50.40 | $21.60 | (57.14%) | +26.19% | (83.33%) |
| 2022 | $107.25 | $50.40 | (53.01%) | (18.17%) | (34.84%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
